Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 8797316, 6 pages
http://dx.doi.org/10.1155/2016/8797316
Research Article

Relationship of Hemoglobin A1c with β Cell Function and Insulin Resistance in Newly Diagnosed and Drug Naive Type 2 Diabetes Patients

1Department of Endocrinology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China
2China National Heavy Duty Truck Group Corporation Hospital, Jinan, Shandong 250116, China
3Lukang Hospital of Jining, Jining, Shandong 272141, China
4Department of Endocrinology, Second People’s Hospital of Jining, Jining, Shandong 272049, China
5Shantui Community Health Center, Jining, Shandong 272000, China
6Department of Endocrinology, The Second Hospital of Shandong University, Jinan, Shandong 250012, China

Received 13 February 2015; Accepted 26 March 2015

Academic Editor: Francis M. Finucane

Copyright © 2016 Xinguo Hou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. DeFronzo, “Pathogenesis of type 2 diabetes mellitus,” Medical Clinics of North America, vol. 88, no. 4, pp. 787–835, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Weyer, C. Bogardus, D. M. Mott, and R. E. Pratley, “The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus,” Journal of Clinical Investigation, vol. 104, no. 6, pp. 787–794, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Poitout and R. P. Robertson, “Minireview:secondary beta-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity,” Endocrinology, vol. 143, no. 2, pp. 339–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Nathan, J. Kuenen, R. Borg, H. Zheng, D. Schoenfeld, and R. J. Heine, “Translating the A1C assay into estimated average glucose values,” Diabetes Care, vol. 31, no. 8, pp. 1473–1478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Ning, N. Guang, J. Shanghai et al., “Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study,” Journal of Diabetes, vol. 4, no. 2, pp. 172–173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Bi, J. Lu, W. Wang et al., “Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study,” Journal of Diabetes, vol. 6, no. 2, pp. 147–157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Lu, Y. Bi, T. Wang et al., “The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study,” International Journal of Cardiology, vol. 172, no. 2, pp. 388–394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Ning and Z. Bloomgarden, “Diabetes and cancer: findings from the REACTION study,” Journal of Diabetes, vol. 7, no. 2, pp. 143–144, 2015. View at Publisher · View at Google Scholar
  9. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  10. K. G. M. M. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Google Scholar · View at Scopus
  11. Y. Xu, L. Wang, J. He et al., “Prevalence and control of diabetes in Chinese adults,” The Journal of the American Medical Association, vol. 310, no. 9, pp. 948–959, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. DeFronzo and M. A. Abdul-Ghani, “Preservation of β-cell function: the key to diabetes prevention,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 8, pp. 2354–2366, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Marchetti, R. Lupi, S. del Guerra et al., “Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control,” Diabetes Care, vol. 32, supplement 2, pp. S178–S183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. “U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group,” Diabetes, vol. 44, no. 11, pp. 1249–1258, 1995.
  15. R. W. Grant and M. S. Kirkman, “Trends in the evidence level for the American Diabetes Association's ‘Standards of Medical Care in Diabetes’ from 2005 to 2014,” Diabetes Care, vol. 38, no. 1, pp. 6–8, 2005. View at Publisher · View at Google Scholar
  16. F. S. Fang, X. L. Cheng, Y. P. Gong et al., “Association between glycemic indices and beta cell function in patients with newly diagnosed type 2 diabetes,” Current Medical Research and Opinion, vol. 30, no. 8, pp. 1437–1440, 2014. View at Publisher · View at Google Scholar
  17. E. Zini, M. Osto, M. Franchini et al., “Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat,” Diabetologia, vol. 52, no. 2, pp. 336–346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Kaneto, Y. Nakatani, D. Kawamori, T. Miyatsuka, and T. A. Matsuoka, “Involvement of oxidative stress and the JNK pathway in glucose toxicity,” The Review of Diabetic Studies, vol. 1, no. 4, pp. 165–174, 2004. View at Publisher · View at Google Scholar